NEW YORK & MAINZ, GERMANY--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2...
Download the AMAC App
"*" indicates required fields
Copyright © 2024 AMAC, Inc. / AMAC Senior Resources Network. All rights reserved.